Ubiquitination-IN-1 (compound 24) is a ubiquitination and Cksl-Skp2 protein-protein interaction ( IC 50 =0.17 μM) inhibitor. Ubiquitination-IN-1 increases levels of p27. Ubiquitination-IN-1 has the potential for treatment disease by blocking the degradation of tumor suppressors.
In Vitro
Ubiquitination-IN-1 inhibits A549 and HT1080 cells with IC 50 s of 0.91 and 0.4 μM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.